On 18th November 2020, Kaohsiung Medical University Chung-Ho Memorial Hospital, ASUS and ACT Genomics, signed a letter of intent for a Strategic Partnership. The partnership agreement intends to combine ACT Genomics’ NGS (Next Generation Sequencing) database with ASUS’s AICS (ASUS Intelligent Cloud Services) to develop an “Artificial Intelligence (AI) and Medical Big-Data Search System” that targets precision cancer treatment at Kaohsiung Medical University Chung-Ho Memorial Hospital.
The new system will allow doctors to quickly search the tumor gene mutation database for patients, and predict the tumor size and marker index after patients have received medication-assisted treatment. Consequently, doctors will be able to develop a treatment plan with maximum efficacy and minimal side effects.
The ceremony was witnessed by the Chairman of the Board of Trustees of Kaohsiung Medical University, Jian-Zhi Chen, during which time Professor Yuh-Jyh Jong President of Kaohsiung Medical University mentioned that the combination of AI and medical data would provide objective analysis and prediction capabilities at different treatment stages from prevention to acute medical treatment, and thus it would improve medical care quality tremendously.
Professor Yin-Wen Chung, Superintendent of Kaohsiung Medical University Chung-Ho Memorial Hospital, emphasized that AICS’ natural language processing technology was like acquiring a modern missile guidance system in the Stone Age, enabling doctors to have ful control and accurate critical information to fight against diseases and bolster the quality and quantity of cancer treatment.